Serum biomarkers for prediction of mortality in patients with COVID-19.

Rohit S LoombaEnrique G VillarrealJuan S FariasGaurav AggarwalSaurabh AggarwalSaul Flores

Published in: Annals of clinical biochemistry (2021)

This pooled analysis of 10 studies including 1584 patients identified significant differences in biomarkers on admission in patients who survived from those who did not. Further research is needed to develop risk stratification models to help with judicious use of limited health-care resources.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
cardiovascular events
cardiovascular disease
coronary artery disease
patient reported outcomes